Data Sheet 1_A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.csv

Introduction<p>Grade II/III gliomas are invasive brain tumors with a high risk of malignant progression and significant clinical heterogeneity, highlighting the urgent need for reliable prognostic biomarkers to guide personalized treatment strategies. This study aimed to investigate the molecu...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	Jun Mou (4113313) (author)
Другие авторы:	Min Zhang (111999) (author), Fumin Qin (21898700) (author), Yajie Cui (10289612) (author), Keyou Xu (10532345) (author), Baoye Pang (21898703) (author), Xinyue Li (628935) (author), Wanyi Tan (10589471) (author), Aiqi Yang (21898706) (author), Yaxin Liu (4163428) (author), Lingjun Shen (21898727) (author), Yanting Liu (586127) (author), Kai Xu (122914) (author)
Опубликовано:	2025
Предметы:	Genetic Immunology grade II/III gliomas mitochondrial oxidative phosphorylation prognostic gene signature RiskScore model immune microenvironment
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Data Sheet 1_A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.csv

Схожие документы